Evidence method
Level · gp.fundamentals.capex_revenue_ratio
21.08% · OPTIONAL · NOT_ENOUGH_HISTORY
TransMedics Group, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
21.08% · OPTIONAL · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Yoy · gp.fundamentals.revenue
21.18% · CORE · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.inventory_revenue_ratio
28.68% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.gross_margin
58.16% · CORE · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.operating_margin
7.64% · CORE · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
14.30% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.sbc_revenue_ratio
5.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.